ICOS and Miyoshi myopathy: Notably, co-upregulation of ICAM-1, ICOS, and CD69 in MOPC-MM and Lag-3, Tim-3, and PD-1 in VK*MYC MM indicated an even higher activation status (Fig. 1C).